Eccentric Biased Exercises Effect on Functional Outcomes in Iliopsoas Tendonitis

NCT07426601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-02-23

No results posted yet for this study

Summary

Hip and pelvis injuries represent 2-5% of all injuries. Among these injuries, groin pain is the most common finding. The most common injuries in the hip, pelvis, and thigh area are musculotendinous, (eg, quadriceps strain, adductor tendinitis) and, less commonly, iliopsoas tendinitis). Iliopsoas tendonitis is an inflammation of the tendon or area surrounding the tendon. Major causes of iliopsoas tendinitis are acute trauma and overuse resulting from repetitive hip flexion. Patients often present with anterior hip or groin pain of insidious onset. Initially, the patient may note pain after the onset of aggravating activity with resolution soon afterward.

The hip may be held in slight flexion and external rotation to ease tension on the musculotendinous unit. The patient's gait may demonstrate a shortened stride length on the affected side and increased knee flexion in the heel strike and midstance phases.This study aims to determine effects of eccentric biased exercises on pain ,ROM and quality of life in patients with iliopsoas tendonitis.

This Randomised controlled trial will be conducted at Riphah Rehab Training and Research Center in Lahore over time span of 9-month period. A sample size of 44 Participants age 20 to 55 meeting the inclusion criteria will be selected informed consent will be signed by the participants. Participants will be divided into two groups .

Group A will be controlled group receiving the standard physical therapy. Group B will be experimental group which will receive eccentric biased exercises. Outcome measures will be pain measured by Numeric Pain Rating scale, Range of Motion will be assessed by universal goniometer and quality of Life will be measured by HAGOS Score. Inclusion criteria include patients within age group 20-55 both male, female and trangenders included who have pain in hip groin region Exclusion criteria Include patients with any sign of inflammation ,severe pain ,trauma and fracture are excluded. Data will be analyzed using IBMM SPSS 25.0

Conditions

  • Iliopsoas Syndrome
  • Eccentric Exercise Training

Interventions

OTHER

ECCENTRIC BIASED EXERCISES FOR ILIOPSOAS TENDONITIS

Experimental: INTERVENTIONAL GROUP Arm Description: ECCENTRIC BIASED EXERCISES FOR ILIOPSOAS TENDONITIS he subject assumed the right side lying position with a Perform Better. ● black monster band secured around the left ankle and the other end attached to a sturdy object behind her at about knee height. ● The left hip will be maximally flexed with the knee flexed as well. This start position is similar to a running position. ● To start the exercise, the subject slowly extended the hip, controlling against the pull into hip extension provided by the monster band for a count of "3" while keeping the knee flexed, until the hip was fully extended . ● stretch on the iliopsoas at end range hip extension will be done ● The subject will made a quick concentric contraction to the count of "1" quickly flexed the hip against the resistance of the band to move the left hip into full hip flexion to the start position. ● The subject will be cued not to arch her back and to keep her abdominals engag

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Saba Rafique, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2025-11-10
Completion
2025-12-22

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07426601 on ClinicalTrials.gov